Publications by authors named "Nicolas Bovy"

Claim this Profile
F
First-in-human, double-blind, randomized phase 1b study of peptide immunotherapy IMCY-0098 in new-onset type 1 diabetes: an exploratory analysis of immune biomarkers.
Jean Van Rampelbergh, Peter Achenbach, Richard David Leslie, Martin Kindermans, Frédéric Parmentier, Nicolas Bovy

BMC Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-human, double-blind, randomized phase 1b study of peptide immunotherapy IMCY-0098 in new-onset type 1 diabetes.
Jean Van Rampelbergh, Peter Achenbach, Richard David Leslie, Mohammad Alhadj Ali, Colin Dayan, Nicolas Bovy

BMC Med· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunologic mechanisms of a short-course of Lolium perenne peptide immunotherapy: A randomized, double-blind, placebo-controlled trial.
Hanisah Sharif, Iesha Singh, Lubna Kouser, Ralph Mösges, Marie-Alix Bonny, Nicolas Bovy

J Allergy Clin Immunol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lolium perenne peptides for treatment of grass pollen allergy: A randomized, double-blind, placebo-controlled clinical trial.
Mohamed H Shamji, Jan Ceuppens, Claus Bachert, Peter Hellings, Gaël Placier, Nicolas Bovy

J Allergy Clin Immunol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating microRNA-based screening tool for breast cancer.
Pierre Frères, Stéphane Wenric, Meriem Boukerroucha, Corinne Fasquelle, Jérôme Thiry, Nicolas Bovy

Oncotarget· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endothelial exosomes contribute to the antitumor response during breast cancer neoadjuvant chemotherapy via microRNA transfer.
Nicolas Bovy, Benoît Blomme, Pierre Frères, Stella Dederen, Olivier Nivelles

Oncotarget· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant Chemotherapy in Breast Cancer Patients Induces miR-34a and miR-122 Expression.
Pierre Frères, Claire Josse, Nicolas Bovy, Meriem Boukerroucha, Ingrid Struman

J Cell Physiol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miRNA cargo within exosome-like vesicle transfer influences metastatic bone colonization.
Karmele Valencia, Diego Luis-Ravelo, Nicolas Bovy, Iker Antón, Susana Martínez-Canarias

Mol Oncol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MiR-205 is downregulated in hereditary hemorrhagic telangiectasia and impairs TGF-beta signaling pathways in endothelial cells.
Sebastien P Tabruyn, Sylvain Hansen, Maria-Luisa Ojeda-Fernández, Nicolas Bovy, Roberto Zarrabeitia

Angiogenesis· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA-21 exhibits antiangiogenic function by targeting RhoB expression in endothelial cells.
Céline Sabatel, Ludovic Malvaux, Nicolas Bovy, Christophe Deroanne, Vincent Lambert

PLoS One· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis